NEK2 and pituitary tumor: Moreover, a recent study demonstrated that NEK2, whose overexpression significantly promotes pituitary tumor growth and cell proliferation, is upregulated in resistant prolactinomas (29), thereby impairing cellular sensitivity to cabergoline.